| Oct 6 |
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Morgan Stanley Overweight & Quality Stock?
|
| Oct 6 |
Regeneron co-founder warns of harms from weight-loss drugs: FT
|
| Oct 5 |
Regeneron Pharmaceuticals, Inc. (REGN): A Buzzing AI Health Stock to Add to Your Portfolio
|
| Oct 5 |
Should You Buy the Dip on This Top Growth Stock?
|
| Sep 30 |
Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD
|
| Sep 29 |
Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
|
| Sep 29 |
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
|
| Sep 29 |
Regeneron: Long-Term Defensive Investment
|
| Sep 28 |
Regeneron, Sanofi announce Dupixent approval in China for patients with COPD
|
| Sep 28 |
Wall Street Breakfast: What Moved Markets
|
